Trial intelligence / Profile preview

Topical abalone haemocyanin for recurrent herpes labialis

ACTRN12611000920998Phase 2Recruiting

Sponsor
Marine Biotechnology Australia
Start
Aug 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of abalone haemocyanin in herpes labialis (2 arms), sponsored by Marine Biotechnology Australia. Primary endpoint: Duration of cold sore episode. Started Aug 2011; status: recruiting.

02

Drugs

abalone haemocyanin
03

Conditions

herpes labialis

Beyond the preview

Go deeper on ACTRN12611000920998.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611000920998.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call